@pulmoncdoc

Thoracic, Head and Neck Oncologist @VAMinneapolis, assistant professor of medicine @UMNews, thoracic Fellow @Mayocancercare, MPH @JohnsHopkinsSPH

 Minneapolis, MN
Joined February 2016
  • Tweets220
  • Following1.3K
  • Followers405
22Media
Dr. Aditi Singh retweeted
Papa Heme
@Papa_HemeOct 10
Academic docs doing disparities research? I can think of many better ways to help with healthcare disparities. Try practicing in Nevada or really any community with not enough healthcare. Boston doesn’t need anymore docs.
14
16
1
238
23,923
🎙️ New Episode Alert: Research Report Podcast! What does it take to run a landmark clinical trial AND build a thriving research career — all within the VA? In our second episode, we sat down with @DrewMoghanaki , MD, MPH, FASTRO to pull back the curtain on the VALOR trial.
AVAHO
@avahocaresOct 2
The Research Report episode 2 is now LIVE! 🥼 Join our hosts as they're joined by special guest, @DrewMoghanaki to discuss his combined work within UCLA academic medical center and the VA, the VALOR trial, building a research career, mentorship and more! 🟣 Apple Podcasts - podcasts.apple.com/us/podcas… 🟢 Spotify - open.spotify.com/show/6PKkBT… #MedicalPodcast #HemOnc #ClinicalResearch
2
2
553
Dr. Aditi Singh retweeted
AVAHO
@avahocaresSep 28
Learn more about Dr. Jennifer Weiss, one of our speakers in AVAHO's upcoming October Regional Meeting! Don't miss this opportunity to learn about the Genetics and Hereditary Cancer Syndromes Associated with Colorectal Cancer. Registration is OPEN and we'd love to see you there! REGISTER TODAY - bit.ly/avahocrcregional #MedEd #HemOnc
1
38
Dr. Aditi Singh retweeted
AVAHO
@avahocaresAug 21
On this episode our hosts, Julie Lawson and Nick Burwick, discuss everything you need to know about the upcoming AVAHO 2026 Annual Meeting. Learn what makes our Annual Meetings special, the benefits they bring to attendees, and what to expect in-person and online! Give us a listen and subscribe on your favorite podcast platforms! 🫶 🟣 Apple Podcasts - podcasts.apple.com/us/podcas… 🟢 Spotify - open.spotify.com/episode/5yU… #MedicalPodcast #HemOnc #AVAHO2026
2
1
2
385
New clinical trial now open 🧪🫁 Alliance A082402 is studying if targeted post op radiation (I² PORT) can reduce recurrence in high risk #NSCLC patients after surgery while limiting side effects. Learn more bit.ly/I-PORT-Trial. #LungCancer #ClinicalTrials #RadiationTherapy
1
2
163
Now recruiting! @BradMcG04 of @DanaFarber leads @ALLIANCE_org A032201 (STRIKE) to see if adding the anti-cancer drug tivozanib to the standard treatment of immunotherapy after surgery helps patients with high-risk renal cell cancer. Learn more: bit.ly/Alliance-A032201 #NCI
3
4
370
Dr. Aditi Singh retweeted
JTO & JTO CRR
@JTOonline18 Nov 2025
Carbone et al. showed that mesothelioma in patients with the BAP1+/- mutation is biologically, histologically, and clinically distinct, requiring a tailored treatment approach. Read more in this month's JTO: bit.ly/3K5KSBj
14
21
3,134
A082101 led @AMansfieldMD of @MayoClinic evaluates the safety & effectiveness of immunotherapy before surgery for #mesothelioma. #Immunotherapy helps the body’s immune system fight cancer. Learn more: bit.ly/Alliance-A082101 @thenci #nctn
1
3
1
14
715
Does immunotherapy in #SCLC delay brain metastases? Retrospective report @LungCaJournal on 550 pts show pts treated with atezolizumab + carbo/etop longer time to intracranial progression: 24.4 vs 14.3m and if no PCI: 27.2 vs 15.2m. Improved PFS and OS. lungcancerjournal.info/artic…
2
26
4
86
5,138
Report on NGS in squamous NSCLC @LungCaJournal from Dr. @Joshua_Reuss et al. Detected actionable genomic alterations in 22.2% of patients with squamous NSCLC and no history of smoking including #EGFR and #MET. In those with prior smoking, AGAs in 2.4%. lungcancerjournal.info/artic…

Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of...

Comprehensive next-generation sequencing (NGS) has become paramount to the appropriate work-up and management of advanced non-small cell lung cancer (NSCLC). The detection of actionable genomic...

lungcancerjournal.info
1
30
2
87
6,973
Dr. Aditi Singh retweeted
Thor Halfdanarson
@OncoThor1 Oct 2024
esmo.org/guidelines/guidelin…
Dr Amol Akhade
@SuyogCancer1 Oct 2024
How to manage rare endocrine and Neuroendocrine Tumors. 1- intrathyroid Thymic Carcinoma 2 - parathyroid Carcinoma. 3 - metastatic Unknown primary , GuGy Or HN NEN 4- local or Locoregional head and neck NEN Very useful for clinical practice. Taken from @myESMO latest guidelines @OncoThor @OncBrothers @OncoAlert
1
4
939
Dr. Aditi Singh retweeted
Thor Halfdanarson
@OncoThor16 Sep 2024
Hot off the press, Alliance CABINET! Cabozantinib in previously treated (93% had SSA, 60% had PRRT, 72% had everolimus) advanced NETs. The primary endpoint, PFS, was significantly better in the cabo arm than placebo. @ALLIANCE_org nejm.org/doi/full/10.1056/NE…

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors | NEJM

Treatment options for patients with advanced neuroendocrine tumors are limited. The efficacy of cabozantinib in the treatment of previously treated, progressive extrapancreatic or pancreatic neuroe...

nejm.org
7
21
2
53
5,714
Dr. Aditi Singh retweeted
Marie Suga, MD@jmsuga9 Sep 2024
Do we need to do cardiac monitoring for all patients on Osimertinib? Congrats to Dr Francisco Martinez, recent KPSF fellowship graduate’s poster at #wclc2024 Bottom line: >800 pts, 3700 ECHOs, only 10 Osi HF events Higher in a fib, CHF hx pts @KPDOR @Rayliukpsfo @LoriSakoda
1
2
16
739
🫁 Lung Cancer - ICIs data 🫁 🌟 Summary of 5-year (long follow-up) data 🌟 NSCLC (NSQ & SQ) #Immunotherapy #Lungcancer #longfollowup #LCSM
2
75
1
214
31,394
Dr. Aditi Singh retweeted
Only In Boston
@OnlyInBOS14 Jun 2024
Make Way for the Celtics. 💚
40
824
66
8,384
347,592
Diets | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… Excellent paper on diets. Robust evidence for Mediterranean diet benefits🫒

Diets | NEJM

The ways in which particular variations in diet influence health and the course of disease remain largely undefined. The authors review the spectrum of types of diet and describe some attributes of...

nejm.org
1
2
7
701
Dr. Aditi Singh retweeted
soria
@jsoriamd9 Apr 2024
EGFR mutants are not a monolithic entity. In fact EGFR mutational status is heterogeneous and EGFR mutated cancers can be Dr Jekyll or Mr Hyde #AACR24 @marinagarassino
2
31
2
92
15,363
Dr. Aditi Singh retweeted
soria
@jsoriamd3 Jun 2024
#ASCO24 environmental signatures in non-smoking lung cancer in Asia
25
2
76
14,793
Management of pregnancy w/ 🫁ca 🚫 1st trimester ✅Dose according to actual body weight ✅Maintain dose intensity 🚫increase/decrease the dose 🚫chemotherapy @ 35-37 of gestation ✅minimum 3-week interval between the last cycle➡️delivery 🚫avoid IO in 2/3 trim 👀🫁-@matteolambe @asco #ASCO24 #lcsm
3
13
32
2,621
Can always trust @jennifermarksmd to summarize a lung session if you happen to miss it. #ASCO24
Jennifer A. Marks, MD@jennifermarksmd3 Jun 2024
🫁Survivorship is a critical in young 🫁sexuality, fertility and pregnancy-related concerns are apart of it 🫁Sexual dysfunct -prevalent underestimated, UNDERMANAGED 🫁Oncofertility counseling should be offered 🫁dx with lung ca during pregnancy, platinum-based (vinka-alkaloid or taxane) can be offered (2/3rd trim) @asco #asco24 #lcsm @matteolambe
4
416
Load more